Nanoviricides (NNVC) Cash from Financing Activities (2010 - 2026)
Nanoviricides (NNVC) reported Cash from Financing Activities of $1.7 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 133.9% from $728,080 a year earlier.
Powered by 
Analysis
Nanoviricides (NNVC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides posted Cash from Financing Activities of $9.02 million, up 70.2% from FY2025.
- Cash from Financing Activities has a five-year compound annual growth rate of -10.0% (FY2021 to FY2026).
- By fiscal year, Cash from Financing Activities came in at $5.3 million in FY2025 (+69.8%), $3.12 million in FY2024, -$94,788 in FY2023 and -$234,716 in FY2022.
- Five-year quarterly Cash from Financing Activities spans a low of -$71,339 in fiscal Q1 2022 and a high of $6.07 million in fiscal Q2 2026.
- Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 49.0%.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$6,742 (Q3 2026), $6.07 million (Q2 2026) and $1.25 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.06 Bn | 1,133.65 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 643.87 Bn | 563.73 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 357.68 Bn | 312.06 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 301.88 Bn | 265.87 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 241.08 Bn | 196.48 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 192.57 Bn | 166.76 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.48 Bn | 118.13 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Nanoviricides | 29.37 Mn | 17.03 Mn | - | 1.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Mn |
| Mar 31, 2026 | -6,742.00 |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 728,080.00 |
| Mar 31, 2025 | 575,503.00 |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Dec 31, 2022 | -23,837.00 |
| Sep 30, 2022 | -70,951.00 |
| Jun 30, 2022 | -32,709.00 |
| Mar 31, 2022 | -69,293.00 |
| Dec 31, 2021 | -61,375.00 |
| Sep 30, 2021 | -71,339.00 |
| Jun 30, 2021 | -70,500.00 |
| Mar 31, 2021 | 6.05 Mn |
| Dec 31, 2020 | -1.07 Mn |
| Sep 30, 2020 | 10.35 Mn |
| Jun 30, 2020 | 9.32 Mn |
API Access
Nanoviricides Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();